GlassScriptPhysician profile
George Mendenhall
NPI 1699925545
$83,206.69
in general payments reported to CMS, 2019-2025
34 companies · $677 in 2025
The $677 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,841 · 2020: $17K · 2021: $36K · 2022: $8,214 · 2023: $11K · 2024: $2,546 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,680 · Food and Beverage: $3,297 · Travel and Lodging: $1,599 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,680.00 |
| Food and Beverage | $3,296.71 |
| Travel and Lodging | $1,599.24 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $42,028.87 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Evera Mri Xt Dr Surescan |
| Abbott Laboratories | $20,447.32 | 2019-2025 | Mitraclip, Aveir, Ensite |
| Medtronic Vascular, INC. | $11,856.17 | 2019-2020 | |
| Boston Scientific Corporation | $3,733.96 | 2019-2025 | Rhythmia Mapping System, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Biotronik INC. | $927.25 | 2019-2023 | Edora 8 Dr-T |
| Cvrx, INC. | $614.25 | 2021-2025 | Barostim Neo System |
| Pfizer INC. | $531.32 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $530.35 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $443.79 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $324.13 | 2019-2024 | Xarelto |
| Biosense Webster, INC. | $259.87 | 2019-2024 | Qdot Micro Catheter, Octaray Mapping Catheter |
| E.R. Squibb & Sons, L.L.C. | $225.31 | 2019-2025 | Eliquis |
| Philips North America LLC | $189.66 | 2019-2025 | Ecc Solutions |
| Sanofi-Aventis U.S. LLC | $121.63 | 2019-2024 | |
| Impulse Dynamics (USA) INC. | $117.49 | 2022-2025 | Optimizer |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $115.28 | 2019-2023 | |
| Novo Nordisk INC | $111.78 | 2021-2024 | Rybelsus, Ozempic |
| Baxter Healthcare | $93.24 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Amgen INC. | $89.78 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.70 | 2020-2022 | |
| Irhythm Technologies, INC. | $53.63 | 2022-2023 | Zio Xt Patch |
| Cardiva Medical, INC. | $47.64 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $38.53 | 2022 | |
| Cardiofocus, INC. | $29.95 | 2023 | Heartlight System |
| Kestra Medical Technology Services, INC. | $29.64 | 2024 | Assure Wcd |
| Preventice Services, LLC | $28.63 | 2021 | |
| Bardy Diagnostics, INC. | $28.00 | 2020-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $27.49 | 2022 | |
| Acutus Medical, INC. | $26.52 | 2019 | |
| Merck Sharp & Dohme LLC | $24.62 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $19.30 | 2024 | Arcalyst |
| Lantheus Medical Imaging, INC. | $17.95 | 2019 | |
| Itamar Medical INC | $14.27 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $3.37 | 2023 | Uptravi, Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Mendenhall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.